Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by mbeaudeon May 02, 2017 7:23pm

176 Views

Post# 26195399

RE:Invitation to new members

Thank you. I have been following this board since the moment I bought shares from Th at the end of february. I appreciate most of the comments and the way people are exchanging comments. I also follow the corporate conference. Like others I have been waiting for the BLA. I was lucky today to find on google the news that Taimed has completed the submission of a Biologics License Application (BLA). The only thing I wanted to do is create my profile and share the info with this board. So here I am. Let's hope it's the begening of something great.

Bullboard Posts

Eminent acquires promising Nevada gold project